Avista Healthcare
Raleigh, N.C., August 1, 2016 – (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq: INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, intend to offer for sale […]
Zurich – July 25, 2016 – Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd. (“Luye”) to sell Acino’s transdermal patch and implant businesses. The divestment includes Acino’s transdermal manufacturing operations, distribution, and R&D capabilities. The divestment is in line with Acino’s strategy of […]
July 7, 2016 – Partners Group, the global private markets investment manager, and Avista Capital Partners (“Avista”), a leading US private equity firm, have sold their interest in Strategic Partners, Inc. (“Strategic Partners”), the leading US provider of medical scrubs and other uniforms, to investment firm New Mountain Capital on behalf of their clients and […]
Raleigh, N.C., May 2, 2016 – INC Research Holdings, Inc. (Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, intend to offer for sale in an underwritten secondary […]
Stockholm, March 11, 2016 – Trimb Healthcare AB (“Trimb”) has acquired CCS Healthcare AB’s (“CCS”) OTC pharmaceutical products in the Nordics. The products, which include Cortimyk (treatment of foot fungus), Hydrokortison CCS (treatment of mild eczema) and Propyless (treatment of dry skin) among others, are well established in their markets and generate total revenues of […]
Yardley, PA, January 28, 2016 – OptiNose, a privately-held specialty biopharmaceutical company, today announced that its licensing partner, Avanir Pharmaceuticals, Inc. has reported that the U.S. Food & Drug Administration (FDA) approved ONZETRA™ Xsail™ (sumatriptan nasal powder), formerly AVP-825, for the acute treatment of migraine with or without aura in adults (see Full Prescribing Information […]
SAYREVILLE, N.J. and MARIETTA, GA., December 4, 2015 – Vertical / Trigen Holdings, LLC (“Vertical / Trigen”) and Osmotica Holdings Corp Limited (“Osmotica”) today announced that they have entered into a definitive agreement to combine, creating a world-class, fully-integrated specialty pharmaceutical and generics company. Vertical / Trigen is a portfolio company of Avista Capital Partners […]
Raleigh, N.C., Dec. 3, 2015 – INC Research Holdings, Inc. (INC Research)(Nasdaq: INCR), a leading, global Phase I to IV contract research organization, today announced the Company was named “Best Contract Research Organization” at the 11th Annual Scrip Awards held Dec. 2 in London. INC was selected from among several leading global CROs by a […]
Raleigh, N.C., December 2, 2015 – INC Research Holdings, Inc. (Nasdaq: INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced the pricing of an underwritten secondary offering by certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers’ Pension Plan, of […]
Effective October 1, 2015, Acino Pharma, an international pharmaceutical company headquartered in Switzerland, acquires Pharma Start, the 9th largest local pharmaceutical company in Ukraine. The acquisition is in line with Acino’s strategy to grow its business by entering selected high potential emerging markets in the CIS Region (Commonwealth of Independent States) in addition to selected […]
Yardley, PA, September 24, 2015 – OptiNose today announced positive results from a second phase III pivotal trial, NAVIGATE I. This follows and helps both to confirm and support the positive results from a first pivotal trial, NAVIGATE II, that were announced in June. The NAVIGATE trials are double-blind, placebo-controlled studies evaluating the safety and […]
Trimb Healthcare AB (“Trimb”) today announced that it has signed an agreement to acquire YouMedical Group BV (“YouMedical”), a Dutch OTC company with operations in key European markets. YouMedical has total annual sales of approximately EUR 16 million, with solid growth and leading brands in niche categories. “Our ambition is to build a leading international […]